IMARC Group, a leading market research company, has recently releases report titled “EPA & DHA Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” The study provides a detailed analysis of the industry, including the global EPA & DHA market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the EPA & DHA market?
The global EPA & DHA market size reached US$ 1,877.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,228.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032.
Factors Affecting the Growth of the EPA & DHA Industry:
- Increasing Health Awareness:
The surge in health consciousness among consumers is a pivotal factor driving the demand for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Individuals are becoming more attuned to the nuances of nutritional science, recognizing the specific benefits of omega-3 fatty acids such as EPA and DHA. These compounds are essential fats that the body cannot produce on its own, necessitating their intake through diet or supplements. Furthermore, research has linked them to a plethora of health advantages, including significant roles in reducing inflammation, enhancing brain function, and lowering the risk of heart disease. Moreover, the growing media coverage, health blogs, nutritional experts, and scientific studies disseminating knowledge about the importance of these fatty acids for overall health and well-being are driving the market growth.
- Rising Incidence of Chronic Disease:
The escalating prevalence of chronic diseases is a critical factor driving the demand for EPA and DHA. Conditions such as cardiovascular diseases, type 2 diabetes, obesity, and neurological disorders are rising rapidly due to modern lifestyle choices that include poor dietary habits, lack of physical activity, and increasing stress levels. In this regard, omega-3 fatty acids, particularly EPA and DHA, are renowned for their cardioprotective properties, including the ability to improve heart health by reducing triglycerides, lowering blood pressure, and decreasing the risk of arrhythmias. Furthermore, they play a protective role in brain health, potentially slowing cognitive decline. Additionally, public and private health entities are intensifying their efforts to combat these health issues, leading to a stronger push for integrating these vital nutrients into daily diets.
- Growing Geriatric Population:
Technological advancements in extraction methods, such as supercritical CO2 technology, which have improved the efficiency and purity of omega-3 extraction, making the end products more appealing due to their higher quality and stability, are supporting the market growth. Furthermore, innovation in encapsulation and emulsification technologies, which have enabled the incorporation of EPA and DHA into a wider array of products, ranging from pharmaceuticals to functional foods, without compromising the sensory attributes of the final product, is contributing to the market growth. These technological enhancements not only reduce waste and increase the sustainability of production but also expand the potential applications of EPA and DHA in various industries. Additionally, such technologies cater to the growing consumer demand for products that are both effective and environmentally sustainable, thereby fueling the market growth.
Request for a free sample copy of this report: https://www.imarcgroup.com/epa-dha-market/requestsample
Global EPA & DHA Market Trends:
The development of improved extraction techniques and processing technologies, which have made it easier and more cost-effective to include EPA and DHA in various products, is propelling the market growth. Additionally, rapid expansion in application areas, as EPA and DHA are increasingly being incorporated into functional foods, infant formulas, pharmaceuticals, and pet foods, is fueling the market growth. Besides this, the imposition of supportive government regulations, recognizing the importance of omega-3 fatty acids, and boosting consumer confidence are driving the market growth. Furthermore, the expansion of aquaculture, which has increased the availability of fish oil, is catalyzing the market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Market Breakup by Type:
- Eicosapentaenoic Acid (EPA)
- Docosahexaenoic Acid (DHA)
Docosahexaenoic acid (DHA) holds the majority of the market share due to its critical role in brain development and vision health, making it a popular choice in prenatal supplements and infant formulas.
Market Breakup by Source:
- Fish Oil
- Algae Oil
- Krill Oil
- Others
Fish oil accounted for the largest market share due to its established supply chains and recognized health benefits, making it the leading source segment.
Market Breakup by Application:
- Infant Formulae
- Dietary Supplements
- Fortified Food and Beverages
- Pharmaceuticals
- Others
Dietary supplements represented the largest segment, as they are a primary vehicle for EPA and DHA intake, especially in populations with low dietary fish consumption.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Asia Pacific's dominance in the market is attributed to its large population, growing health awareness, and increasing disposable incomes, coupled with a traditional preference for fish-based diets.
Who are the key players operating in the industry?
The report covers the major market players including:
- AlgiSy BioSciences Inc.
- Arctic Nutrition AG
- BASF SE
- Biosearch Sau
- Corbion NV
- Croda International PLC
- KD Pharma Group
- Koninklijke DSM NV
- Nordic Naturals Inc
- Novasep Holding SAS
- Novotech Nutraceuticals Inc
- Omega Protein Corporation
- Polaris
Browse the full report with TOC & List of Figures: https://www.imarcgroup.com/epa-dha-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
